Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > How the market can react when it notices a company

<< Previous

Bullboard Posts

Next >>

Comment by Chianchinon Jul 19, 2021 5:32pm

118 Views

Post# 33573050

RE:How the market can react when it notices a company

Fools day again. Moderna up GUD down. There is absolutely no comparison between the two. Moderna developed vaccines in less than one Year and has tens of billion of sales world wide. GUD sells few small potatos new drugs and many few other old drugs. Sales a couple hundreds milllions and looses money.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season